shortagewatch

Home / Cancer and immune system / Carboplatin

ATC L01XA02 · Antineoplastic Agents

Carboplatin shortage

As of 31 Oct 2026, Carboplatin has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Spain, Belgium), covering 15 products.

Countries4/5
Products15packs or presentations
Short since20 Mar 20242.6 years ago
Earliest return29 Nov 2026company estimate
No return date10products
Main reasonManufacturing problem
Germany1 pack shortItaly11 packs shortSpain2 packs shortAustriaNo reported shortageBelgium1 pack short

Timeline

GermanyItalySpainBelgium
20252026Carboplatin Accord 10 mg/ml Konzentrat zur HCarboplatin Accord 10 mg/ml Konzentrat zur Herstellung einer InfusionslösungCARBOPLATINO AHCLCARBOPLATINO AHCLCARBOPLATINO TEVACARBOPLATINO TEVACARBOPLATINO MEDACCARBOPLATINO MEDACCARBOPLATINO MEDACCARBOPLATINO MEDACCARBOPLATINO PFIZERCARBOPLATINO PFIZERCARBOPLATINO AUROBINDO ITALIACARBOPLATINO AUROBINDO ITALIACARBOPLATINO PFIZERCARBOPLATINO PFIZERCARBOPLATINO MEDACCARBOPLATINO MEDACCARBOPLATINO PFIZERCARBOPLATINO PFIZERCARBOPLATINO MEDACCARBOPLATINO MEDACCARBOPLATINO MEDACCARBOPLATINO MEDACCARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARCARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 15 mlCARBOPLATINO HIKMA 10 MG/ML SOLUCION PARA PECARBOPLATINO HIKMA 10 MG/ML SOLUCION PARA PERFUSION EFG, 1 vial de 15 mlCarboplatin Accord Healthcare 10 mg/ml inf. Carboplatin Accord Healthcare 10 mg/ml inf. sol. (conc.) i.v. vial 15 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DECarboplatin Accord 10 mg/ml Konzentrat zur Herstellung einer InfusionslösungAccord Healthcare B.V.15 May 202630 Nov 2026Manufacturing problem
Herstellerwechsel
ITCARBOPLATINO AHCLACCORD HEALTHCARE BV20 Mar 2024not givenManufacturing problem
Problemi produttivi: forniture discontinue
ITCARBOPLATINO TEVATEVA PHARMA B.V.1 Jul 2025not givenManufacturing problem
Problemi produttivi
ITCARBOPLATINO MEDACMEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH10 Jul 2025not givenCommercial decision or withdrawal
Motivi commerciali
ITCARBOPLATINO MEDACMEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH10 Jul 2025not givenCommercial decision or withdrawal
Motivi commerciali
ITCARBOPLATINO PFIZERPFIZER ITALIA S.R.L.31 Jul 2025not givenManufacturing problem
Problemi produttivi
ITCARBOPLATINO AUROBINDO ITALIAEugia Pharma (Malta) Limited7 May 2026not givenManufacturing problem
Problemi produttivi
ITCARBOPLATINO PFIZERPFIZER ITALIA S.R.L.1 Jul 202631 Dec 2026Increased demand
Elevata richiesta
ITCARBOPLATINO MEDACMEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH5 Aug 2026not givenIncreased demand
Elevata richiesta
ITCARBOPLATINO PFIZERPFIZER ITALIA S.R.L.1 Sep 202631 Mar 2027Manufacturing problem
Problemi produttivi
ITCARBOPLATINO MEDACMEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH19 Oct 2026not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ITCARBOPLATINO MEDACMEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH19 Oct 2026not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ESCARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 15 mlAccord Healthcare S.L.U.16 Nov 2025not givenNot stated
ESCARBOPLATINO HIKMA 10 MG/ML SOLUCION PARA PERFUSION EFG, 1 vial de 15 mlHikma Farmaceutica (Portugal) S.A.26 Oct 202629 Nov 2026Not stated
BECarboplatin Accord Healthcare 10 mg/ml inf. sol. (conc.) i.v. vial 15 mlAccord Healthcare10 Mar 202631 Dec 2026Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Cisplatin Oxaliplatin